phenoxymethylpenicillin ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
antibiotics, 6-aminopenicillanic acid derivatives 2083 87-08-1

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • penicillin v
  • penicillin v potassium
  • phenopenicillin
  • meropenin
  • phenoxymethylpenicillin
  • phenoxymethylpenicillinic acid
A broad-spectrum penicillin antibiotic used orally in the treatment of mild to moderate infections by susceptible gram-positive organisms.
  • Molecular weight: 350.39
  • Formula: C16H18N2O5S
  • CLOGP: 1.94
  • LIPINSKI: 0
  • HAC: 7
  • HDO: 2
  • TPSA: 95.94
  • ALOGS: -2.89
  • ROTB: 5

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
2 g O

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 4 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 0.45 mg/mL Bocci G, Oprea TI, Benet LZ
MRTD (Maximum Recommended Therapeutic Daily Dose) 71.35 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD
Vd (Volume of distribution) 0.41 L/kg Lombardo F, Berellini G, Obach RS
CL (Clearance) 6.80 mL/min/kg Lombardo F, Berellini G, Obach RS
fu (Fraction unbound in plasma) 0.45 % Lombardo F, Berellini G, Obach RS
t_half (Half-life) 0.84 hours Lombardo F, Berellini G, Obach RS

Approvals:

DateAgencyCompanyOrphan
Jan. 13, 1958 FDA WYETH AYERST

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Drug hypersensitivity 349.22 17.50 280 6656 310407 63171679
Rash 125.65 17.50 221 6715 560650 62921436
Myocardial depression 121.95 17.50 24 6912 480 63481606
Lip swelling 118.86 17.50 61 6875 31002 63451084
Decorticate posture 114.30 17.50 21 6915 286 63481800
Swelling face 68.08 17.50 56 6880 63419 63418667
Lipase increased 64.24 17.50 28 6908 9872 63472214
Ventricular hypokinesia 57.72 17.50 21 6915 4623 63477463
Urticaria 48.49 17.50 74 6862 165728 63316358
Eosinophilia 47.26 17.50 30 6906 22726 63459360
Hypothermia 47.13 17.50 25 6911 13556 63468530
Oral discomfort 46.93 17.50 22 6914 9179 63472907
Gastric cancer 46.48 17.50 18 6918 4705 63477381
Lichen nitidus 45.28 17.50 8 6928 86 63482000
Rash macular 44.08 17.50 29 6907 23335 63458751
Hypersensitivity 44.05 17.50 98 6838 292587 63189499
Toxic epidermal necrolysis 41.95 17.50 29 6907 25305 63456781
Coma scale abnormal 41.52 17.50 17 6919 5136 63476950
Drug reaction with eosinophilia and systemic symptoms 40.82 17.50 32 6904 33804 63448282
Swollen tongue 37.91 17.50 31 6905 34769 63447317
Respiratory depression 30.78 17.50 19 6917 13696 63468390
Pancreatitis 30.59 17.50 32 6904 49023 63433063
Agranulocytosis 28.66 17.50 23 6913 25111 63456975
Acute respiratory distress syndrome 27.83 17.50 22 6914 23512 63458574
Encephalopathy 27.37 17.50 27 6909 38593 63443493
Hepatocellular injury 26.94 17.50 23 6913 27358 63454728
Intentional overdose 25.85 17.50 36 6900 74116 63407970
Unresponsive to stimuli 24.63 17.50 24 6912 33792 63448294
Hepatobiliary infection 24.30 17.50 4 6932 27 63482059
Cross sensitivity reaction 24.01 17.50 9 6927 2153 63479933
Adenovirus reactivation 23.59 17.50 5 6931 146 63481940
Granulomatous dermatitis 23.27 17.50 5 6931 156 63481930
Mouth swelling 23.14 17.50 11 6925 4729 63477357
Pruritus 22.99 17.50 89 6847 361364 63120722
Oligohydramnios 22.88 17.50 12 6924 6354 63475732
Lichenification 22.80 17.50 6 6930 450 63481636
Subacute combined cord degeneration 21.49 17.50 5 6931 225 63481861
Obstructive airways disorder 19.57 17.50 17 6919 20682 63461404
Intravascular haemolysis 19.39 17.50 5 6931 346 63481740
Eye swelling 19.37 17.50 18 6918 23900 63458186
Joint swelling 19.14 17.50 6 6930 327660 63154426
Drug ineffective 18.51 17.50 56 6880 1044709 62437377
Cytomegalovirus viraemia 18.48 17.50 10 6926 5639 63476447
Left ventricular dysfunction 18.16 17.50 13 6923 11975 63470111
Graft versus host disease in skin 18.14 17.50 8 6928 2897 63479189
Rheumatoid arthritis 18.10 17.50 3 6933 253816 63228270
Pulmonary function test abnormal 18.09 17.50 7 6929 1823 63480263

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Spinal muscular atrophy 113.03 18.49 24 7034 372 34949501
Pneumococcal sepsis 97.25 18.49 26 7032 1111 34948762
Acute generalised exanthematous pustulosis 89.78 18.49 38 7020 6738 34943135
Drug hypersensitivity 89.40 18.49 95 6963 80434 34869439
Disease complication 82.52 18.49 28 7030 2708 34947165
Increased bronchial secretion 80.10 18.49 25 7033 1856 34948017
Motor neurone disease 80.01 18.49 19 7039 498 34949375
Sputum increased 78.40 18.49 26 7032 2344 34947529
Stoma closure 74.46 18.49 16 7042 263 34949610
Respiratory tract infection bacterial 73.02 18.49 23 7035 1759 34948114
Nocardiosis 72.48 18.49 28 7030 3923 34945950
Ischaemic cerebral infarction 72.18 18.49 21 7037 1226 34948647
Lower respiratory tract infection bacterial 70.24 18.49 17 7041 484 34949389
Chest X-ray abnormal 66.13 18.49 27 7031 4371 34945502
Bronchial disorder 65.45 18.49 20 7038 1383 34948490
Lymphadenectomy 63.95 18.49 15 7043 372 34949501
Rash 63.45 18.49 139 6919 222613 34727260
Resuscitation 60.56 18.49 19 7039 1434 34948439
Metabolic disorder 60.01 18.49 25 7033 4258 34945615
Brief psychotic disorder with marked stressors 54.66 18.49 12 7046 219 34949654
Lung consolidation 52.18 18.49 25 7033 5911 34943962
Scoliosis 51.96 18.49 20 7038 2773 34947100
Cerebral ischaemia 50.69 18.49 25 7033 6297 34943576
Brain injury 48.39 18.49 24 7034 6118 34943755
Motor dysfunction 48.36 18.49 25 7033 6949 34942924
Demyelination 45.79 18.49 19 7039 3202 34946671
Swelling face 44.36 18.49 37 7021 23068 34926805
Pyrexia 43.96 18.49 157 6901 332856 34617017
Intestinal ischaemia 43.00 18.49 24 7034 7770 34942103
Morganella infection 40.24 18.49 11 7047 511 34949362
Drug reaction with eosinophilia and systemic symptoms 40.23 18.49 41 7017 32971 34916902
Inflammation 39.79 18.49 38 7020 28257 34921616
Pleocytosis 39.63 18.49 11 7047 541 34949332
Staphylococcal mediastinitis 37.89 18.49 7 7051 50 34949823
Bronchial haemorrhage 36.91 18.49 11 7047 698 34949175
Atelectasis 35.30 18.49 29 7029 17698 34932175
Muscle atrophy 33.39 18.49 20 7038 7384 34942489
Graft versus host disease 31.49 18.49 22 7036 10547 34939326
Secretion discharge 29.39 18.49 17 7041 5888 34943985
Thrombotic microangiopathy 29.07 18.49 21 7037 10609 34939264
Plasma cell myeloma 29.03 18.49 39 7019 41998 34907875
Prothrombin level abnormal 28.69 18.49 6 7052 86 34949787
Injury 27.60 18.49 27 7031 20660 34929213
Circulatory collapse 27.22 18.49 27 7031 21011 34928862
Toxoplasmosis 26.55 18.49 10 7048 1306 34948567
Tachypnoea 26.47 18.49 25 7033 18327 34931546
Death 26.39 18.49 25 7033 398024 34551849
Mechanical ventilation 25.92 18.49 11 7047 1959 34947914
Disseminated varicella zoster virus infection 25.84 18.49 7 7051 314 34949559
Lung infiltration 25.45 18.49 21 7037 12884 34936989
Axonal neuropathy 24.73 18.49 9 7049 1068 34948805
Endotracheal intubation 24.21 18.49 12 7046 3053 34946820
Brain abscess 23.99 18.49 12 7046 3113 34946760
Sinusitis bacterial 23.18 18.49 7 7051 465 34949408
Cytomegalovirus oesophagitis 22.70 18.49 7 7051 499 34949374
Antipsychotic drug level decreased 21.51 18.49 8 7050 1009 34948864
Osteomyelitis chronic 21.42 18.49 6 7052 305 34949568
Conjunctivitis bacterial 21.39 18.49 5 7053 122 34949751
Acute lymphocytic leukaemia recurrent 21.35 18.49 11 7047 3033 34946840
Respiratory arrest 20.87 18.49 27 7031 28016 34921857
Rash papular 20.85 18.49 17 7041 10261 34939612
Parvovirus B19 infection 19.09 18.49 7 7051 848 34949025
Pharyngeal oedema 18.98 18.49 13 7045 6034 34943839

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Rash 158.07 14.99 306 12235 578052 79153795
Drug hypersensitivity 130.31 14.99 195 12346 298721 79433126
Lip swelling 120.77 14.99 77 12464 40834 79691013
Spinal muscular atrophy 112.65 14.99 23 12518 380 79731467
Myocardial depression 112.06 14.99 24 12517 505 79731342
Swelling face 106.92 14.99 89 12452 71123 79660724
Decorticate posture 104.38 14.99 21 12520 321 79731526
Pneumococcal sepsis 93.89 14.99 26 12515 1636 79730211
Motor neurone disease 81.66 14.99 19 12522 589 79731258
Stoma closure 76.81 14.99 16 12525 293 79731554
Drug reaction with eosinophilia and systemic symptoms 71.89 14.99 68 12473 64176 79667671
Respiratory tract infection bacterial 70.96 14.99 22 12519 2055 79729792
Nocardiosis 69.39 14.99 28 12513 5651 79726196
Increased bronchial secretion 68.37 14.99 24 12517 3303 79728544
Lower respiratory tract infection bacterial 63.54 14.99 17 12524 939 79730908
Bronchial disorder 63.04 14.99 21 12520 2468 79729379
Disease complication 62.60 14.99 25 12516 4912 79726935
Acute generalised exanthematous pustulosis 62.43 14.99 37 12504 17217 79714630
Sputum increased 60.72 14.99 24 12517 4589 79727258
Ischaemic cerebral infarction 58.72 14.99 20 12521 2515 79729332
Chest X-ray abnormal 54.39 14.99 26 12515 7857 79723990
Brief psychotic disorder with marked stressors 54.16 14.99 12 12529 297 79731550
Resuscitation 51.93 14.99 18 12523 2386 79729461
Brain injury 50.51 14.99 28 12513 11489 79720358
Lymphadenectomy 50.12 14.99 15 12526 1244 79730603
Eosinophilia 46.94 14.99 46 12495 45299 79686548
Lung consolidation 45.51 14.99 24 12517 8923 79722924
Rash macular 45.17 14.99 37 12504 28862 79702985
Metabolic disorder 44.95 14.99 24 12517 9146 79722701
Morganella infection 43.02 14.99 13 12528 1114 79730733
Lichen nitidus 42.12 14.99 8 12533 89 79731758
Swollen tongue 41.87 14.99 42 12499 42528 79689319
Scoliosis 40.76 14.99 21 12520 7443 79724404
Thrombotic microangiopathy 40.61 14.99 30 12511 20139 79711708
Cerebral ischaemia 40.48 14.99 24 12517 11171 79720676
Granulomatous dermatitis 40.25 14.99 10 12531 411 79731436
Staphylococcal mediastinitis 39.51 14.99 7 12534 51 79731796
Ventricular hypokinesia 36.47 14.99 21 12520 9258 79722589
Toxic skin eruption 35.80 14.99 29 12512 22264 79709583
Drug ineffective 35.66 14.99 73 12468 1080840 78651007
Oral discomfort 35.49 14.99 21 12520 9739 79722108
Pyrexia 35.26 14.99 204 12337 678505 79053342
Encephalopathy 35.16 14.99 48 12493 67349 79664498
Motor dysfunction 34.44 14.99 24 12517 14709 79717138
Intestinal ischaemia 34.30 14.99 23 12518 13247 79718600
Demyelination 33.80 14.99 19 12522 8004 79723843
Pleocytosis 31.95 14.99 11 12530 1428 79730419
Muscle atrophy 30.32 14.99 20 12521 11212 79720635
Rash papular 30.01 14.99 26 12515 21890 79709957
Coma scale abnormal 29.81 14.99 18 12523 8660 79723187
Eye swelling 29.56 14.99 28 12513 26440 79705407
Graft versus host disease 29.46 14.99 22 12519 15004 79716843
Bronchial haemorrhage 28.96 14.99 10 12531 1310 79730537
Hepatobiliary infection 28.65 14.99 5 12536 33 79731814
Toxic epidermal necrolysis 28.32 14.99 35 12506 44546 79687301
Cross sensitivity reaction 27.93 14.99 13 12528 3699 79728148
Brain abscess 27.28 14.99 14 12527 4922 79726925
Hypothermia 27.20 14.99 25 12516 22721 79709126
Mechanical ventilation 24.98 14.99 11 12530 2753 79729094
Hypersensitivity 24.80 14.99 94 12447 262145 79469702
Mouth swelling 24.60 14.99 14 12527 6037 79725810
Pharyngeal oedema 23.69 14.99 20 12521 16252 79715595
Bone marrow transplant rejection 23.55 14.99 6 12535 273 79731574
Rash maculo-papular 23.49 14.99 36 12505 56042 79675805
Plasma cell myeloma 23.45 14.99 35 12506 53224 79678623
Death 23.44 14.99 33 12508 566481 79165366
Haemolysis 23.44 14.99 18 12523 12794 79719053
Malaise 23.29 14.99 144 12397 489725 79242122
Atelectasis 23.23 14.99 27 12514 32230 79699617
Disseminated varicella zoster virus infection 22.87 14.99 7 12534 626 79731221
Tonsil cancer 22.38 14.99 8 12533 1160 79730687
Endotracheal intubation 22.20 14.99 12 12529 4685 79727162
Toxoplasmosis 22.03 14.99 10 12531 2687 79729160
Antipsychotic drug level decreased 22.01 14.99 8 12533 1216 79730631
Hepatocellular injury 22.00 14.99 32 12509 47561 79684286
Cytomegalovirus oesophagitis 21.61 14.99 7 12534 753 79731094
Axonal neuropathy 21.27 14.99 9 12532 2045 79729802
Secretion discharge 20.92 14.99 18 12523 15004 79716843
Fall 20.57 14.99 28 12513 487601 79244246
Parvovirus B19 infection 20.53 14.99 8 12533 1472 79730375
Obstructive airways disorder 20.46 14.99 25 12516 31434 79700413
Agranulocytosis 20.41 14.99 30 12511 45000 79686847
Herpes simplex reactivation 20.34 14.99 6 12535 473 79731374
Gastric cancer 20.17 14.99 15 12526 10164 79721683
Urticaria 19.70 14.99 69 12472 185132 79546715
Lung infiltration 19.63 14.99 21 12520 22891 79708956
Graft versus host disease in skin 19.33 14.99 12 12529 6061 79725786
Tachypnoea 18.50 14.99 24 12517 32039 79699808
Cholestasis 18.46 14.99 31 12510 52078 79679769
Circulatory collapse 18.40 14.99 26 12515 37642 79694205
Unresponsive to stimuli 18.20 14.99 32 12509 55756 79676091
Osteomyelitis chronic 18.07 14.99 6 12535 698 79731149
Cryptosporidiosis infection 17.75 14.99 6 12535 737 79731110
Subacute combined cord degeneration 17.73 14.99 5 12536 336 79731511
Pulmonary vasculitis 17.61 14.99 6 12535 755 79731092
Joint swelling 17.47 14.99 12 12529 288634 79443213
Adenovirus reactivation 17.08 14.99 5 12536 384 79731463
Septic shock 16.91 14.99 50 12491 122751 79609096
Respiratory syncytial virus infection 16.74 14.99 13 12528 9389 79722458
Acute lymphocytic leukaemia recurrent 16.74 14.99 10 12531 4714 79727133
Pharyngeal swelling 16.71 14.99 12 12529 7707 79724140
Conjunctivitis bacterial 16.37 14.99 5 12536 444 79731403
Injury 16.30 14.99 37 12504 77459 79654388
Acanthamoeba infection 15.79 14.99 5 12536 500 79731347
Sinusitis bacterial 15.79 14.99 7 12534 1780 79730067
Conversion disorder 15.52 14.99 7 12534 1854 79729993
Hepatic enzyme increased 15 14.99 5 12536 182605 79549242

FDA Adverse Event Reporting System (Pediatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Plagiocephaly 23.20 10.71 4 4 64 89720

Pharmacologic Action:

SourceCodeDescription
ATC J01CE02 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIBACTERIALS FOR SYSTEMIC USE
BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Beta-lactamase sensitive penicillins
FDA CS M0016152 Penicillins
FDA EPC N0000175497 Penicillin-class Antibacterial
MeSH PA D000900 Anti-Bacterial Agents
MeSH PA D000890 Anti-Infective Agents

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Acute otitis media indication 3110003
Infection of skin AND/OR subcutaneous tissue indication 19824006
Gingivostomatitis indication 20607006
Scarlet fever indication 30242009 DOID:8596
Streptococcal tonsillitis indication 41582007
Erysipelas indication 44653001 DOID:11330
Upper respiratory infection indication 54150009
Streptococcus pyogenes infection indication 302809008
Infective otitis media indication 312218008
Fusospirochetal pharyngitis indication 399095008
Pharyngitis indication 405737000 DOID:2275
Infection due to Staphylococcus aureus indication 406602003
Pneumococcal Acute Otitis Media indication
Upper Respiratory Pneumococcal Infection indication
Infection Prevention from Tooth Extraction indication
Rheumatic Fever Prevention indication
Upper Respiratory Streptococcal Infection indication
Actinomycotic infection off-label use 11817007 DOID:8478
Lyme disease off-label use 23502006 DOID:11729
Infection due to anaerobic bacteria off-label use 423451008
Pneumococcal Infection Prevention in Sickle Cell Disease off-label use
Kidney disease contraindication 90708001 DOID:557
Infectious mononucleosis contraindication 271558008 DOID:8568
Pseudomembranous enterocolitis contraindication 397683000




๐Ÿถ Veterinary Drug Use

SpeciesUseRelation
Cats Respiratory infections caused by pathogens Indication
Cats Urogenital infections caused by pathogens Indication
Cats Skin and soft tissue infections caused by pathogens Indication
Cats Septicemia caused by pathogens Indication
Dogs Treatment of respiratory, urogenital, skin, and soft tissue infections and septicemia caused by pathogens Indication

๐Ÿถ Veterinary products

ProductApplicantIngredients
Penicillin VK Filmtab 250 mg Boehringer lngelheim Animal Health USA Inc. 1

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.79 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Bacterial penicillin-binding protein Enzyme INHIBITOR CHEMBL CHEMBL
Penicillin-binding protein 1A Enzyme WOMBAT-PK

External reference:

IDSource
N0000011298 NUI
D05411 KEGG_DRUG
132-98-9 SECONDARY_CAS_RN
4017436 VANDF
C0030840 UMLSCUI
CHEBI:27446 CHEBI
PNV PDB_CHEM_ID
CHEMBL615 ChEMBL_ID
CHEMBL1200852 ChEMBL_ID
DB00417 DRUGBANK_ID
10920 IUPHAR_LIGAND_ID
6869 PUBCHEM_CID
203195 RXNORM
179406 MMSL
2179 MMSL
5248 MMSL
d07730 MMSL
002684 NDDF
002686 NDDF
372725003 SNOMEDCT_US
39359008 SNOMEDCT_US
56723006 SNOMEDCT_US
D010404 MESH_DESCRIPTOR_UI
518 INN_ID
Z61I075U2W UNII

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-1172 TABLET 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-1172 TABLET 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-1172 TABLET 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-1174 TABLET 500 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-1174 TABLET 500 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-1174 TABLET 500 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-4125 POWDER, FOR SOLUTION 125 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-4125 POWDER, FOR SOLUTION 125 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-4125 POWDER, FOR SOLUTION 125 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-4127 POWDER, FOR SOLUTION 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-4127 POWDER, FOR SOLUTION 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0093-4127 POWDER, FOR SOLUTION 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0143-9836 TABLET, FILM COATED 500 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0143-9836 TABLET, FILM COATED 500 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0143-9837 TABLET, FILM COATED 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0143-9837 TABLET, FILM COATED 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0440-2055 TABLET 250 mg ORAL ANDA 14 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0440-8055 TABLET 250 mg ORAL ANDA 14 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 0440-8056 TABLET 500 mg ORAL ANDA 14 sections
Penicillin V Potasium HUMAN PRESCRIPTION DRUG LABEL 1 0781-1205 TABLET 250 mg ORAL ANDA 15 sections
Penicillin V Potasium HUMAN PRESCRIPTION DRUG LABEL 1 0781-1655 TABLET 500 mg OROPHARYNGEAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 10544-075 TABLET, FILM COATED 500 mg ORAL ANDA 14 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 10544-296 TABLET 250 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 10544-297 TABLET 500 mg ORAL ANDA 15 sections
Penicillin V Potassium HUMAN PRESCRIPTION DRUG LABEL 1 10544-500 TABLET 500 mg ORAL ANDA 15 sections
Penicillin V Potasium HUMAN PRESCRIPTION DRUG LABEL 1 10544-975 TABLET 500 mg ORAL ANDA 16 sections
Penicillin V Potassium Human Prescription Drug Label 1 16714-234 TABLET, FILM COATED 250 mg ORAL ANDA 14 sections
Penicillin V Potassium Human Prescription Drug Label 1 16714-234 TABLET, FILM COATED 250 mg ORAL ANDA 14 sections
Penicillin V Potassium Human Prescription Drug Label 1 16714-235 TABLET, FILM COATED 500 mg ORAL ANDA 14 sections
Penicillin V Potassium Human Prescription Drug Label 1 16714-235 TABLET, FILM COATED 500 mg ORAL ANDA 14 sections